Publication | Closed Access
Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial.
47
Citations
25
References
2010
Year
MGN-3 in conjunction with IT may be useful for the treatment of hepatocellular carcinoma and warrants further investigation in multiple clinical trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1